Cost-effectiveness of a short stay admission programme for breast cancer surgery

Acta Oncologica

Volumn 49, Issue 3, 2010, Pages 338-346

  De Kok, Mascha ^a   Dirksen, Carmen D ^a   Kessels, Alfons G ^a   Van Der Weijden, Trudy ^a   Van De Velde, Cornelis J ^b   Roukema, Jan A ^c   Bell, Antoine V ^d   Van Der Ent, Fred W ^e   Von Meyenfeldt, Maarten F ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CPRLab   (Netherlands)

^d LAURENTIUS HOSPITAL   (Netherlands)

^e Sittard Geleen Heerlen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURGERY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SOCIETY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HEALTH CARE COSTS; HOME NURSING; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MARITAL STATUS; MIDDLE AGED; NETHERLANDS; PROGRAM EVALUATION; QUALITY-ADJUSTED LIFE YEARS; SOCIOECONOMIC FACTORS;

EID: 77951274021     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841861003610192     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
2. Comprehensive Cancer Centres. 2006. Retrieved from http:// www.ikcnet.nl (in Dutch).
3. RIVM, National Institute for Public Health and the Environment. 2009. Retrieved from http://www.rivm.nl (in Dutch).
4. Bonnema J, van Wersch AM, van Geel AN, Pruyn JF, Schmitz PI, Paul MA, et al. Medical and psychosocial effects of early discharge after surgery for breast cancer: Randomised trial. BMJ 1998;316(7140):1267-1271 (Pubitemid 28181934)
5. Bundred N, Maguire P, Reynolds J, Grimshaw J, Morris J, Thomson L, et al. Randomised controlled trial of effects of early discharge after surgery for breast cancer. BMJ 1998;317(7168):1275-1279 (Pubitemid 28502407)
6. Purushotham AD, McLatchie E, Young D, George WD, Stallard S, Doughty J, et al. Randomized clinical trial of no wound drains and early discharge in the treatment of women with breast cancer. Br J Surg 2002;89:286-292 (Pubitemid 34227025)
7. Bonnema J, van Wersch AM, van Geel AN, Pruyn JF, Schmitz PI, Uyl-de Groot CA, et al. Cost of care in a randomised trial of early hospital discharge after surgery for breast cancer. Eur J Cancer 1998;34:2015-2020 (Pubitemid 28546934)
8. Evans WK, Will BP, Berthelot JM, Logan DM, Mirsky DJ, Kelly N. Breast cancer: Better care for less cost. Is it possible? Int J Technol Assess Health Care 2000;16: 1168-1178
9. Edwards MJ, Broadwater JR, Bell JL, Ames FC, Balch CM. Economic impact of reducing hospitalization for mastectomy patients. Ann Surg 1988;208:330-336
10. de Kok M, Frotscher CN, van der Weijden T, Kessels AG, Dirksen CD, van de Velde CJ, et al. Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: Framework for an implementation study. BMC Cancer 2007;7:117.
11. EuroQol--a new facility for the measurement of h ealth-related quality of life. The EuroQol Group. Health Policy 1990;16: 199-208.
12. Brooks R. Euro Qol: The current state of play. Health Policy 1996;37:53-72. (Pubitemid 26191458)
13. Dolan P, Roberts J. Modelling valuations for Eq-5d health states: An alternative model using differences in valuations. Med Care 2002;40:442-446
14. Koopmanschap MA, Rutten FF. Berekening van kosten van zorg; Vaak onderschat in economische evaluaties. Nederlands Tijdschrift voor gezondheidswetenschappen 1998;76:83-88 (in Dutch).
15. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek: Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Rotterdam: College voor zorgverzekeringen. Geactualiseerde versie; 2004.
16. Gold MR, Siegel JR, Russell LB, Weinstein MC. Cost-Effectiveness in health and medicine. New York: Oxford University Press; 1996.
17. Board of Governors of the Federal Reserve System. 2008. Retrieved from http://www.federalreserve.gov.
18. Statistics Netherlands. www.cbs.nl. Voorburg/Heerlen; 2008.
19. The Genees-en hulpmiddelen Informatie Project databank. College voor zorgverzekeringen; 2006. Retrieved from http:// www.gipdatabank.nl.
20. Schafer JL, Graham JW. Missing data: Our view of the state of the art. Psychol Method 2002;7:147-177
21. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confi dence interval estimation. Health Econ 1997;6:327-340
22. van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994;3:309-319
23. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ. [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]. Ned Tijdschr Geneeskd 2005;149:1574-1578 (Pubitemid 40978328)
24. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: A review of methodology and transparency. Health Econ 2004;13:1203-1210 (Pubitemid 40017242)
25. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005;14:1523-1532